- Home
- STBA vs KNSA Comparison
STBA vs KNSA Comparison
Compare STBA & KNSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STBA
- KNSA
- Stock Information
- Founded
- STBA 1902
- KNSA 2015
- Country
- STBA United States
- KNSA United Kingdom
- Employees
- STBA N/A
- KNSA N/A
- Industry
- STBA Major Banks
- KNSA Biotechnology: Pharmaceutical Preparations
- Sector
- STBA Finance
- KNSA Health Care
- Exchange
- STBA Nasdaq
- KNSA Nasdaq
- Market Cap
- STBA 1.5B
- KNSA 1.4B
- IPO Year
- STBA N/A
- KNSA 2018
- Fundamental
- Price
- STBA $39.36
- KNSA $20.02
- Analyst Decision
- STBA Hold
- KNSA Strong Buy
- Analyst Count
- STBA 1
- KNSA 5
- Target Price
- STBA $41.00
- KNSA $36.60
- AVG Volume (30 Days)
- STBA 166.5K
- KNSA 567.6K
- Earning Date
- STBA 04-17-2025
- KNSA 02-25-2025
- Dividend Yield
- STBA 3.46%
- KNSA N/A
- EPS Growth
- STBA N/A
- KNSA N/A
- EPS
- STBA 3.41
- KNSA N/A
- Revenue
- STBA $383,756,000.00
- KNSA $384,098,000.00
- Revenue This Year
- STBA N/A
- KNSA $60.10
- Revenue Next Year
- STBA $5.82
- KNSA $34.22
- P/E Ratio
- STBA $11.55
- KNSA N/A
- Revenue Growth
- STBA N/A
- KNSA 54.41
- 52 Week Low
- STBA $28.83
- KNSA $16.56
- 52 Week High
- STBA $45.79
- KNSA $28.15
- Technical
- Relative Strength Index (RSI)
- STBA 49.06
- KNSA 53.15
- Support Level
- STBA $39.43
- KNSA $19.31
- Resistance Level
- STBA $40.90
- KNSA $20.20
- Average True Range (ATR)
- STBA 1.46
- KNSA 0.80
- MACD
- STBA -0.01
- KNSA 0.06
- Stochastic Oscillator
- STBA 51.20
- KNSA 72.80
About STBA S&T Bancorp Inc.
S&T Bancorp Inc is a bank holding company. The company operates in five markets including Western Pennsylvania, Eastern Pennsylvania, Northeast Ohio, Central Ohio and Upstate New York. It has one reporting unit, Community Banking. The company provides financial services with retail and commercial banking products, cash management services, trust and brokerage services. The company earns revenue from interest on loans and securities and fees charged for financial services provided to its customers.
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.